Tolerance and Efficacy Nicotinamide (Vitamin B3) in Dominant Optic Atrophy OPA1

NCT06007391 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

25

Enrollment

OTHER_GOV

Sponsor class

Conditions

Nicotinamide Adverse Reaction

Interventions

DRUG: Nicotinamide

Sponsor

University Hospital, Angers